TerminatedNCT00794963

Aggressive Treatment of Metabolic Syndrome in Patients Receiving Clozapine for Schizophrenia

Medication studyAges 19–79United States

The study in practice

Understand this study

Listed age limits: 19 years to 79 years.

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Study start dateNovember 2008

Recruitment status: Terminated
Enrollment listed in the registry: 8
Sponsor: Northwell Health
Sponsor type: Unknown or unclear
Study type: Drug
Intervention type: Medication / drug, OTHER
Study phase: Not clearly listed
Locations: United States
Age range: From 19 Years to 79 Years
Official registry ID: NCT00794963
Official title: Show the full official title
Aggressive Treatment of Metabolic Syndrome in Patients Treated With Clozapine for Schizophrenia

Terminated

Glen Oaks

A listed location does not confirm current availability.

FAQ

Who is behind this study?

The study sponsor is Northwell Health.

Does this study involve medication?

Yes. The study involves medication, including Pravastatin, Fenofibrate, Metformin, Orlistat, irbesartan.

Who can participate?

Listed age limits: 19 years to 79 years.

Is this study still recruiting?

The registry lists this study as terminated.